SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-066217
Filing Date
2023-11-27
Accepted
2023-11-27 20:48:47
Documents
2
Period of Report
2023-11-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9152
2 EX-24.1 krro-ex24_1.htm EX-24.1 9971
  Complete submission text file 0000950170-23-066217.txt   20653
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Issuer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FREQUENCY THERAPEUTICS, INC. 19 PRESIDENTIAL WAY, 2ND FLOOR WOBURN MA 01801
Business Address
Lucchino David L. (Reporting) CIK: 0001785288 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39062 | Film No.: 231441689